NuVasive Revenue 2006-2019 | NUVA

NuVasive revenue from 2006 to 2019. Revenue can be defined as the amount of money a company receives from its customers in exchange for the sales of goods or services. Revenue is the top line item on an income statement from which all costs and expenses are subtracted to arrive at net income.
NuVasive Annual Revenue
(Millions of US $)
2018 $1,102
2017 $1,027
2016 $962
2015 $811
2014 $762
2013 $685
2012 $620
2011 $541
2010 $478
2009 $370
2008 $250
2007 $154
2006 $98
2005 $63
NuVasive Quarterly Revenue
(Millions of US $)
Q2 2019 $292
Q1 2019 $275
Q4 2018 $288
Q3 2018 $271
Q2 2018 $282
Q1 2018 $261
Q4 2017 $271
Q3 2017 $247
Q2 2017 $259
Q1 2017 $249
Q4 2016 $271
Q3 2016 $240
Q2 2016 $236
Q1 2016 $215
Q4 2015 $215
Q3 2015 $201
Q2 2015 $203
Q1 2015 $192
Q4 2014 $204
Q3 2014 $190
Q2 2014 $191
Q1 2014 $177
Q4 2013 $191
Q3 2013 $169
Q2 2013 $166
Q1 2013 $160
Q4 2012 $166
Q3 2012 $148
Q2 2012 $154
Q1 2012 $152
Q4 2011 $150
Q3 2011 $133
Q2 2011 $133
Q1 2011 $124
Q4 2010 $129
Q3 2010 $120
Q2 2010 $120
Q1 2010 $109
Q4 2009 $107
Q3 2009 $95
Q2 2009 $88
Q1 2009 $80
Q4 2008 $75
Q3 2008 $67
Q2 2008 $57
Q1 2008 $51
Q4 2007 $47
Q3 2007 $39
Q2 2007 $36
Q1 2007 $33
Q4 2006 $30
Q3 2006 $25
Q2 2006 $23
Q1 2006 $20
Q4 2005 $19
Q3 2005 $15
Q2 2005 $15
Q1 2005 $13
Sector Industry Market Cap Revenue
Medical Medical Products Manufacturing $3.263B $1.102B
NuVasive, Inc. is transforming spine surgery and beyond with minimally invasive, procedurally-integrated solutions designed to deliver reproducible and clinically-proven surgical outcomes. The Company's portfolio includes access instruments, implantable hardware, biologics, and software systems for surgical planning, navigation and imaging solutions, magnetically adjustable implant systems for spine and orthopedics, and intraoperative monitoring service offerings.
Stock Name Country Market Cap PE Ratio
Medtronic (MDT) Ireland $144.122B 20.23
Abbott Laboratories (ABT) United States $141.639B 26.63
Stryker (SYK) United States $79.044B 27.33
Boston Scientific (BSX) United States $52.905B 25.66
Baxter (BAX) United States $44.730B 27.12
EssilorLuxottica Societe Anonyme (ESLOY) France $31.899B 0.00
Zimmer Biomet Holdings (ZBH) United States $27.527B 17.62
Coloplast (CLPBY) Denmark $24.516B 39.14
Lonza Group Ag (LZAGY) Switzerland $24.500B 0.00
Terumo (TRUMY) Japan $23.332B 26.83
Smith & Nephew SNATS (SNN) United Kingdom $20.451B 0.00
ResMed (RMD) United States $18.758B 35.74
Sunny Optical Technology (SNPTF) China $16.343B 0.00
Bio-Rad Laboratories (BIO) United States $9.664B 51.80
Insulet (PODD) United States $9.336B 553.21
Canopy Growth (CGC) Canada $7.103B 0.00
Perrigo (PRGO) Ireland $7.075B 13.03
Hill-Rom Holdings (HRC) United States $6.550B 19.53
Haemonetics (HAE) United States $6.367B 48.05
William Demant Holdings (WILYY) Denmark $5.988B 0.00
GN STORE NORD (GNNDY) Denmark $5.322B 27.49
Shandong Weigao Medical Polymer (SHWGF) China $4.296B 0.00
Aurora Cannabis (ACB) Canada $3.796B 0.00
GW Pharmaceuticals (GWPH) United Kingdom $3.645B 0.00
Neogen (NEOG) United States $3.284B 54.96
ICU Medical (ICUI) United States $3.151B 20.44
Quidel (QDEL) United States $2.356B 23.39
Hutchison China MediTech (HCM) Hong Kong, SAR China $2.303B 0.00
Agios Pharmaceuticals (AGIO) United States $1.869B 0.00
National Vision Holdings (EYE) United States $1.827B 39.44
Cardiovascular Systems (CSII) United States $1.586B 0.00
Aphria (APHA) $1.164B 0.00
VAREX IMAGING (VREX) United States $1.064B 24.53
AtriCure (ATRC) United States $0.978B 0.00
Phibro Animal Health (PAHC) United States $0.849B 13.81
Eagle Pharmaceuticals (EGRX) United States $0.823B 20.97
Omeros (OMER) United States $0.745B 0.00
NanoString Technologies (NSTG) United States $0.737B 0.00
PetIQ (PETQ) United States $0.722B 17.07
Lantheus Holdings (LNTH) United States $0.721B 18.96
Cerus (CERS) United States $0.623B 0.00
LeMaitre Vascular (LMAT) United States $0.622B 36.89
Surmodics (SRDX) United States $0.569B 108.08
MacroGenics (MGNX) United States $0.553B 0.00
Quanterix (QTRX) United States $0.529B 0.00
TG Therapeutics (TGTX) United States $0.491B 0.00
OraSure Technologies (OSUR) United States $0.461B 21.34
Owens & Minor (OMI) United States $0.410B 12.28
Meridian Bioscience (VIVO) United States $0.377B 11.76
Zynex (ZYXI) United States $0.362B 38.41
Utah Medical Products (UTMD) United States $0.349B 25.56
Neptune Technologies & Bioresources Inc (NEPT) Canada $0.312B 0.00
BioLife Solutions (BLFS) United States $0.304B 93.44
United Health Products (UEEC) United States $0.242B 0.00
Bovie Medical (APYX) United States $0.223B 0.00
Vapotherm (VAPO) United States $0.167B 0.00
Rockwell Medical (RMTI) United States $0.156B 0.00
Cytosorbents (CTSO) United States $0.137B 0.00
Female Health (VERU) United States $0.134B 0.00
Fonar (FONR) United States $0.127B 8.93
Chimerix (CMRX) United States $0.100B 0.00
Chembio Diagnostics (CEMI) United States $0.097B 0.00
United-Guardian (UG) United States $0.084B 19.84
Nephros (NEPH) United States $0.068B 0.00
MTech Acquisition (KERN) United States $0.061B 0.00
Oramed Pharmaceuticals (ORMP) United States $0.055B 0.00
ImmuCell (ICCC) United States $0.037B 0.00
Surface Oncology (SURF) United States $0.033B 0.00
Trinity Biotech (TRIB) Ireland $0.023B 0.00
Senestech (SNES) United States $0.023B 0.00
GUARDION HEALTH (GHSI) United States $0.021B 0.00
Conatus Pharmaceuticals (CNAT) United States $0.011B 0.00
Capricor Therapeutics (CAPR) United States $0.009B 0.00
Valeritas Holdings (VLRX) United States $0.007B 0.00
Akers Biosciences Inc (AKER) United States $0.005B 0.00
NeuroMetrix (NURO) United States $0.003B 0.00